Introduction
The adult mammalian central nervous system (CNS) is remarkably efficient at replacing myelin forming cells following primary demyelination 1 . This regenerative process is called remyelination. While in most circumstances the new myelin forming cells are oligodendrocytes, the myelinating cells of the CNS, it is also well-established in both experimental models and clinical disease that remyelination can be mediated by Schwann cells, the myelinating cells of the peripheral nervous system (PNS) [2] [3] [4] [5] [6] [7] [8] .
New remyelinating oligodendrocytes are generated from a population of neural progenitor cells widely distributed throughout the adult CNS [9] [10] [11] . These cells can be identified using a range of markers, of which two commonly used are Pdgfra and NG2, and are generally referred to as oligodendrocyte progenitor cells (or OPCs) 12 . In the past, it was assumed that all Schwann cells engaged in remyelinating CNS axons were derived from PNS Schwann cells, and entered the CNS through breaches in the astrocytic glia limitans 13, 14 . While this is certainly a source of some CNS Schwann cells 10 , transplantation 15 and, more especially, genetic fate mapping studies 10 
Materials and Methods

Animals
The mouse line containing a conditional phosphorylated Stat3 (pStat3) knockout in astrocytes (GFAP-STAT3-CKO) on a C57BL6 background was kindly provided by Dr.
Michael 
Toxin induced demyelination
Focal spinal cord demyelination was created as previously described 24 . Briefly, [8] [9] [10] week old mice were anaesthetized with isoflurane and the spinal cord was exposed at the level of T12/T13 by removing the soft tissue between the vertebrae. 1μl of 1% L-alysophosphatidylcholine (lysolecithin -Sigma-Aldrich, Gilingham, UK) in sterile saline was injected using a Hamilton syringe fitted with a fine glass tip into the ventral spinal cord white matter ( Fig.1.A) . At designated time points after injection, mice were terminally anaesthetized with an overdose of pentobarbital before being perfused transcardially with either 4% paraformaldehyde for immunohistochemistry, or 4% glutaraldehyde for resin embedding and electron microscopy.
Immunohistochemistry
Immunohistochemistry was performed on 12µm thick frozen sections. Where required, heat mediated antigen retrieval with 10mM sodium citrate buffer (pH 6) was performed prior to standard protocol for indirect immunofluorescence staining. Briefly, slide 
In situ Hybridization
In situ hybridisation of digoxigenin (DIG) labelled cRNA probes for myelin protein zero (mpz) and myelin proteolipid protein (plp) was performed as previously described 26 .
Briefly, sections were hybridised with DIG-labelled cRNA probes at 65°C overnight and 
Electron microscopy
Animals were perfused with 4% glutaraldehyde in PBS containing 0.4mM CaCl2. The spinal cord was coronally sliced at 1mm thickness and treated with 2% osmium tetroxide overnight before being subjected to a standard protocol for epoxy resin embedding 24 . Lesions were localised on semithin 1μm sections stained with toluidine blue. Ultrathin sections of the lesion site were cut onto copper grids and stained with uranyl acetate before being examined with a Hitachi H-600 Transmission Electron
Microscope.
Quantification and Statistics
For each animal, three demyelinated lesion sections, separated by approximately 120 µm, were selected from within the central region of the lesion. For immunostaining, the outline of each lesion was defined based on the increase in cellularity inside the lesion, as visualised by Hoechst 33342 counterstain. For in situ hybridisation, the outline was defined based on the lesioned tissue texture, using Zeiss AxioVision software. The numbers of marker-positive cells inside the lesions were manually counted using ImageJ, and normalized against the lesion area. The average of 3 sections was used for each lesioned animal. For each group, 4-5 animals were used. To compare differences between the control and experimental group, a two way ANOVA followed by Bonferroni post test was used and the threshold for statistical significance was set at p<0.05.
Results
Expression of phosphorylated Stat3 in astrocytes is reduced in GFAP-STAT3-CKO mice following toxin-induced CNS demyelination
Phosphorylation of Stat3 is increased in multiple CNS cell types during injury [25] [26] [27] . To verify this in our demyelination model we examined the expression of phosphorylated Stat3 (pStat3) in control, non-Cre expressing lesioned and unlesioned mice, using a pStat3 specific antibody. To obtain a focal demyelinating lesion, animals were injected with 1% lysolecithin solution into the ventral spinal cord ( Fig.1.A) . In normal unlesioned spinal cord, very few cells were found to express pStat3 (not shown). In contrast, there was a marked increase in pStat3 expression 5 days post lesion (dpl), (Fig.1.B) . The pStat3 levels remained elevated at 14 and 21 dpl, albeit somewhat decreased from the expression at 5dpl (Fig.1.B) . The staining was most intense within the nucleus (Fig.1.D 23 , resulting in a mutant unable to phosphorylate Stat3 in astrocytes (GFAP-STAT3-CKO mice). We first investigated pStat3 expression in lesioned GFAP-STAT3-CKO mice. As expected, the number pStat3 expressing astrocytes, as examined by colabelling with astrocyte markers Gfap (Fig.1.C-I ) and aldehyde dehydrogenase 1 (Aldh1l1) 28 surrounding pStat3+ nuclei, was significantly lower in the mutants compared to controls (Fig.1.J-L) .
Demyelination-associated astrogliosis is reduced in GFAP-STAT3-CKO mice
Lysolecithin demyelination is characterised by an abundance of astrocytes within the lesioned area ( Fig.1 .C-L; Fig.2 .A-D). In control mice, we observed an increase in Gfap immunoreactivity within and beyond the demyelinated area (the latter determined by the lipophilic dye Sudan Black) (Fig.2.A, B ). An increase in Gfap expression was also seen in demyelinated areas of spinal cord in GFAP-STAT3-CKO mice, when compared to unlesioned tissue surrounding the lesioned areas ( Fig.1.H; Fig.2.C,D) , although the intensity of the staining was lower than in control animals (not shown). Because Gfap staining localises to astrocytic processes that often form a tangled mesh in injured tissue, rendering quantification of individual positive cells challenging, we instead compared the areas occupied by reactive astrocytes in control and GFAP-STAT3-CKO spinal cord lesions, as defined by a clear boundary of increased Gfap reactivity. We found the relative area of reactive astrocytes over total lesion area to be reduced in GFAP-STAT3-CKO mice at both 5 and 14 dpl (Fig.2.E ). This was verified by counting the number of Aldh1l1+ cells in demyelinated areas, which revealed a significant 40-60% reduction in GFAP-STAT3-CKO mice compared to controls at all three survival time points examined (Fig.2.G) .
Reducing Stat3 activation in astrocytes does not alter macrophage responses to demyelination
Abrogation of Stat3 activation results in spreading of inflammation following a spinal cord crush injury 23, 29 . To assess the influence of astrocytic Stat3 knockout in our demyelination model, we examined the microglia/macrophage response in GFAP-
STAT3-CKO mice following demyelination by immunostaining for Ionized calcium
Binding Adaptor molecule 1 (Iba1). Iba1+ cells were found to be present at high density throughout the lesion (Fig.3 ). Since it is not feasible to quantify microglia/macrophage cellular density due to the fused pattern of immunostaining in lesions, we measured normalised mean optical density to represent the extent of microglia/ macrophage infiltration in the demyelinated area. There was no difference in either Iba1 intensity or area of Iba1+ cell infiltration at all the time points examined (Fig.3.C, D) .
The attenuated astrocyte response reduces oligodendrocyte remyelination
Astrocytes are known to influence OPCs during CNS remyelination 21, [30] [31] [32] . We therefore assessed the impact of the conditional astrocytic pStat3 ablation on oligodendrocyte remyelination, by comparing the distribution of oligodendrocyte lineage cells using different markers expressed at specific stages of lineage progression in control and mutant lesioned mice. In control animals, Olig2+ cell numbers had increased at 5 dpl (when OPCs are actively recruited to the lesion), had increased further at 14 dpl (when differentiation is ongoing) and remained high at 21 dpl (when remyelination is near completion) (Fig.4.A,B and E) . In GFAP-STAT3-CKO animals, the density of Olig2+ cells was comparable to controls at 5 dpl, but had significantly reduced at 14 and 21 dpl (Fig.4 .
C-E).
Increased expression of the transcription factor Sox2 is a marker of OPC activation (unpublished observations). The density of total Sox2+ cells, and Sox2+/Olig2+ colabelled cells in the demyelinated area were significantly lower in the GFAP-STAT3-CKO group compared to controls at 5 and 14 dpl, suggesting impaired OPC activation (Fig.4.F,G) . There was also a reduction in Sox2+ cells that did not express Olig2, which are likely to be astrocytes and is consistent with the data in Fig. 2G . The reduced density of Olig2+ and Olig2+/Sox2+ cells was mirrored by reduced expression of mature oligodendrocyte markers CC1 and plp at 14 and 21 dpl (Fig.5 ).
Schwann cell CNS remyelination is increased as a result of attenuated astrogliosis
The mutual exclusivity of astrocyte presence and Schwann cell remyelination within the same region of repairing demyelinated lesion led us to reason that an attenuated astrocytic response could lead to increased Schwann cell remyelination in GFAP-STAT3-CKO mutants. Indeed, compared to lesioned controls, the GFAP-STAT3-CKO spinal cord white matter lesions showed increased areas of periaxin antigenicity and increased density of myelin protein zero (mpz) mRNA expression at 14 and 21 dpl, indicating increased Schwann cell remyelination (Fig.6.A-I ). The increased number of remyelinating Schwann cells was confirmed by analysing semithin resin sections and performing electron microscopy, where Schwann cells could be readily recognised by their typical 'signet ring' morphology and relatively thicker myelin sheath (Fig.6.J-O) .
Notably, in the GFAP-STAT3-CKO lesions, Schwann cell remyelinated areas contained more demyelinated axons than oligodendrocyte remyelinated areas at all the time 13 points examined (Fig.6.M,N) . Since toxin-induced demyelination invariably undergoes complete remyelination it is likely that these few remaining demyelinated axons will eventually undergo remyelination.
Discussion
In this study, we used a transgenic conditional astrocytic pStat3 knockout model to show that altering astrocyte activation significantly influences the response to CNS demyelination injury. This model had been previously used to study astrogliosis and scar formation in spinal cord trauma 23 . In accordance with this previous study, we found that abrogating astrocyte activation decreased the astrocytic response in the lesion. However, unlike in the trauma model, we found no effect of pStat3 manipulation in astrocytes on macrophage responses 29 . Crucially, our study focused on remyelination and revealed that oligodendrocyte remyelination was reduced and
Schwann cell remyelination increased in lesioned GFAP-STAT3-CKO mice. Our findings therefore constitute the first direct proof of the indispensable role of astrocyte activation in the balance between Schwann cell and oligodendrocyte remyelination in the CNS.
The intriguing phenomenon of Schwann cell remyelination within the CNS has been recognised for many decades, yet its mechanisms and functions remain obscure. It is now known, as a result of genetic fate mapping strategies that, contrary to the previously held belief, many of the Schwann cells that appear in the CNS are not immigrants from the peripheral nervous system but are instead derived from CNS progenitor cells 10 . It has also been recognised that Schwann cell remyelination often occurs around blood vessels and within areas of damaged CNS from which astrocytes are absent 16, 19, 33 . This observation has led to the hypothesis that the presence or What is the functional significance of Schwann cells myelinating CNS axons? There are two main functions of myelin -to allow rapid saltatory conduction and to help maintain axon health and integrity 36 . It has been evidence for many years that Schwann cell myelination restores saltatory conduction to demyelinated CNS axons, and from this perspective it appears to make no difference which type of myelin surrounds the axons 37, 38 . However, the relative effect of peripheral versus central type myelin on axonal integrity is entirely unknown. Schwann cells and oligodendrocytes differ in a number of ways -they develop from different tissues, use different strategies to myelinate target axons, produce different extracellular components and assemble molecularly distinct nodes and paranodes 39 . Moreover, key differences have been shown in their metabolic relationships with the axons they ensheath 40 . It is possible therefore that in the context of recovery from CNS demyelinating injury, Schwann cell CNS remyelination may have distinctive physiological advantages over oligodendrocyte remyelination, although this hypothesis remains to be tested. Certainly, in the context of immune mediated damage directed against epitopes specific to oligodendrocytes and their myelin, one might imagine that Schwann cell would be resistant to direct injury and that therefore this form of remyelination might protect against subsequent oligodendrocyte-directed immune attack.
Our study has shown that substantial reduction of pStat3 mediated astrocyte activation is a sufficient prerequisite to sway the remyelination process towards PNS type remyelination in the CNS. This evidence will help to further elucidate the development and function of peripheral type CNS remyelination, which presents not only an intriguing biological phenomenon but also an interesting and unexplored therapeutic possibility. 
